MK7902-002/E7080-G000-311/LEAP-002

About this trial

Patient Profile

Unresectable hepatocellular carcinoma

Where’s this trial being run?

St Vincents University Hospital and Mater Misericordiae University Hospital

Can I join this study / trial?

The first thing you do is to talk to your doctor and/or the cancer trials research team in your hospital. The contact details for the cancer trials research units in Ireland is here.

Why not Print this page and bring it with you. It will help your doctor and research team advise you.

For more detailed information

Questions?

Here’s a list of questions you may have for your doctor or local cancer research team.


Summary Data

Name: MK7902-002/E7080-G000-311/LEAP-002
Number: CTRIAL-IE 18-43
Full Title:

Phase 3 randomized, double-blinded, active-controlled clinical study to evaluate the safety and efficacy of lenvatinib in combination with pembrolizumab versus lenvatinib alone in first-line intervention of participants with unresectable hepatoceullar carcinoma

Principal Investigator: Ray McDermott
Type: Industry Sponsored
Sponsor:

MSD

Recruitment Started: Global:
Ireland: 10
Global Recruitment Target: 750
Ireland Recruitment Target: